Aspen Pharmacare Holdings Ltd Cash Flow Conversion Efficiency
Aspen Pharmacare Holdings Ltd cash flow conversion efficiency. Based on the latest financial reports, Aspen Pharmacare Holdings Ltd (APN) has a cash flow conversion efficiency ratio of 0.044x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ZAC3.58 Billion ≈ $1.90 Million USD) by net assets (ZAC81.09 Billion ≈ $43.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Aspen Pharmacare Holdings Ltd (2003–2025)
Cash flow conversion efficiency of Aspen Pharmacare Holdings Ltd from 2003 to 2025. This chart illustrates how Aspen Pharmacare Holdings Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View APN share price today for real-time trading data and today's change.
Aspen Pharmacare Holdings Ltd Cash Flow Conversion Ratio Explained
Aspen Pharmacare Holdings Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Aspen Pharmacare Holdings Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Aspen Pharmacare Holdings Ltd ranked by their cash flow conversion efficiency. Also see Aspen Pharmacare Holdings Ltd (APN) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hanwha Solutions
KO:009830
|
0.076x |
|
L&K Engineering Co Ltd
TW:6139
|
0.599x |
|
Hamilton Lane Inc
NASDAQ:HLNE
|
0.056x |
|
Aris Mining Corporation
NYSE MKT:ARMN
|
0.070x |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
0.041x |
|
Harvey Norman Holdings Ltd
AU:HVN
|
0.079x |
|
MAZDA MOTOR UNSP.ADR/2
F:MZA0
|
N/A |
|
Baic Bluepark New Energy Technology
SHG:600733
|
-0.273x |
Annual Cash Flow Conversion Efficiency for Aspen Pharmacare Holdings Ltd (2003–2025)
The table below shows the annual cash flow conversion efficiency of Aspen Pharmacare Holdings Ltd from 2003 to 2025. Review how much free cash does Aspen Pharmacare Holdings Ltd generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | ZAC84.89 Billion ≈ $45.12 Million |
ZAC5.16 Billion ≈ $2.74 Million |
0.061x | -17.16% |
| 2024-06-30 | ZAC84.86 Billion ≈ $45.10 Million |
ZAC6.22 Billion ≈ $3.31 Million |
0.073x | +14.60% |
| 2023-06-30 | ZAC86.24 Billion ≈ $45.83 Million |
ZAC5.52 Billion ≈ $2.93 Million |
0.064x | -15.50% |
| 2022-06-30 | ZAC70.94 Billion ≈ $37.70 Million |
ZAC5.37 Billion ≈ $2.86 Million |
0.076x | -27.16% |
| 2021-06-30 | ZAC65.63 Billion ≈ $34.88 Million |
ZAC6.83 Billion ≈ $3.63 Million |
0.104x | -12.85% |
| 2020-06-30 | ZAC69.22 Billion ≈ $36.79 Million |
ZAC8.26 Billion ≈ $4.39 Million |
0.119x | +7.79% |
| 2019-06-30 | ZAC54.21 Billion ≈ $28.81 Million |
ZAC6.00 Billion ≈ $3.19 Million |
0.111x | -20.96% |
| 2018-06-30 | ZAC50.09 Billion ≈ $26.62 Million |
ZAC7.02 Billion ≈ $3.73 Million |
0.140x | -7.12% |
| 2017-06-30 | ZAC43.10 Billion ≈ $22.91 Million |
ZAC6.50 Billion ≈ $3.45 Million |
0.151x | +100.30% |
| 2016-06-30 | ZAC42.50 Billion ≈ $22.59 Million |
ZAC3.20 Billion ≈ $1.70 Million |
0.075x | -46.84% |
| 2015-06-30 | ZAC34.16 Billion ≈ $18.16 Million |
ZAC4.84 Billion ≈ $2.57 Million |
0.142x | +6.62% |
| 2014-06-30 | ZAC28.88 Billion ≈ $15.35 Million |
ZAC3.84 Billion ≈ $2.04 Million |
0.133x | -24.01% |
| 2013-06-30 | ZAC22.80 Billion ≈ $12.12 Million |
ZAC3.99 Billion ≈ $2.12 Million |
0.175x | +4.59% |
| 2012-06-30 | ZAC17.40 Billion ≈ $9.25 Million |
ZAC2.91 Billion ≈ $1.55 Million |
0.167x | -9.19% |
| 2011-06-30 | ZAC13.29 Billion ≈ $7.06 Million |
ZAC2.45 Billion ≈ $1.30 Million |
0.184x | -1.43% |
| 2010-06-30 | ZAC10.89 Billion ≈ $5.79 Million |
ZAC2.03 Billion ≈ $1.08 Million |
0.187x | -38.39% |
| 2009-06-30 | ZAC4.26 Billion ≈ $2.27 Million |
ZAC1.29 Billion ≈ $686.68K |
0.303x | +54.19% |
| 2008-06-30 | ZAC3.32 Billion ≈ $1.76 Million |
ZAC652.38 Million ≈ $346.71K |
0.197x | -33.71% |
| 2007-06-30 | ZAC2.39 Billion ≈ $1.27 Million |
ZAC708.56 Million ≈ $376.56K |
0.297x | +27.24% |
| 2006-06-30 | ZAC1.73 Billion ≈ $917.16K |
ZAC402.21 Million ≈ $213.76K |
0.233x | -59.58% |
| 2005-06-30 | ZAC1.11 Billion ≈ $588.19K |
ZAC638.20 Million ≈ $339.17K |
0.577x | +23.31% |
| 2004-06-30 | ZAC1.07 Billion ≈ $566.78K |
ZAC498.74 Million ≈ $265.05K |
0.468x | -3.67% |
| 2003-06-30 | ZAC794.98 Million ≈ $422.49K |
ZAC385.95 Million ≈ $205.11K |
0.485x | -- |
About Aspen Pharmacare Holdings Ltd
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic ag… Read more